Login to Your Account



Other news to note


Monday, April 28, 2014
Editas Medicine, of Cambridge, Mass., said data highlighting new approaches to improve the specificity of CRISPR/Cas9 genome-editing technology were published in Nature Biotechnology.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription